Orphan designation: Metreleptin Treatment of familial partial lipodystrophy, 17/07/2012 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 22 October 2024 - 14:40

Orphan designation: Metreleptin Treatment of familial partial lipodystrophy, 17/07/2012 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-12-1022

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters